Company overview
ELGA LabWater manufactures and services water purification systems delivering Type I ultrapure, Type II pure, and Type III general grade water for pharmaceutical R&D, biotech, and clinical labs. Systems use technologies like reverse osmosis, ion-exchange, ultrafiltration, and electrodeionization to meet high-purity needs for experiments and analysis. As part of Veolia Water Technologies, ELGA provides global support with reliable, intuitive solutions for uninterrupted science.
Pure Lab Water For Science is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include lab water purification, ultrapure water systems, pharma water systems, type i water, elga labwater.
Products and technologies associated with Pure Lab Water For Science include Purification — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://us.elgalabwater.com
- Markets served
- United States & Americas
- Keywords
- lab water purification, ultrapure water systems, pharma water systems, type i water, elga labwater
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What water purity levels does ELGA LabWater provide for pharma labs?
- ELGA offers Type I ultrapure, Type II pure, and Type III general grade water systems tailored for pharmaceutical R&D, biotech, and clinical applications.
- What technologies are used in ELGA's purification systems?
- Systems incorporate reverse osmosis, ion-exchange resins, microfiltration, ultrafiltration, UV photooxidation, degassing, and electrodeionization for high-purity lab water.
- Does ELGA provide global service and support for installations?
- Yes, ELGA, backed by Veolia, offers worldwide technical service teams and support for water purification systems in research, healthcare, and pharma environments.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
